Search hospitals > Florida > Miami
University of Miami Miller School of Medicine-Sylvester Cancer Center
Claim this profileMiami, Florida 33136
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Brain Tumor
Conducts research for Lymphoma
793 reported clinical trials
85 medical researchers
Summary
University of Miami Miller School of Medicine-Sylvester Cancer Center is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Brain Tumor, Lymphoma and other specialties. University of Miami Miller School of Medicine-Sylvester Cancer Center is involved with conducting 793 clinical trials across 803 conditions. There are 85 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, and Macarena I. De La Fuente.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Julio C Barredo, MDUniversity of Miami Miller School of Medicine-Sylvester Cancer Center8 years of reported clinical research
Expert in Cancer
Expert in Neuroblastoma
46 reported clinical trials
98 drugs studied
Jose Lutzky, MDUniversity of Miami5 years of reported clinical research
Expert in Melanoma
Studies Skin Cancer
20 reported clinical trials
41 drugs studied
Chukwuemeka (Emeka) V. IkpeazuUniversity of Miami Miller School of Medicine-Sylvester Cancer Center2 years of reported clinical research
Studies Cancer
Studies Pancreatic Cancer
13 reported clinical trials
34 drugs studied
Macarena I. De La FuenteUniversity of Miami Miller School of Medicine-Sylvester Cancer Center6 years of reported clinical research
Studies Brain Tumor
Studies Glioblastoma
12 reported clinical trials
27 drugs studied
Clinical Trials running at University of Miami Miller School of Medicine-Sylvester Cancer Center
Skin Cancer
Lung Cancer
Prostate Cancer
Brain Tumor
Ovarian Cancer
Pancreatic Cancer
Breast Cancer
Cancer
Testicular cancer
Melanoma
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Cemiplimab + Surgery
for Advanced Skin Cancer
This phase III trial compares the effect of adding cemiplimab to standard therapy (surgery with or without radiation) versus standard therapy alone in treating patients with stage III/IV squamous cell skin cancer that is able to be removed by surgery (resectable) and that may have come back after a period of improvement (recurrent). The usual treatment for patients with resectable squamous cell skin cancer is the removal of the cancerous tissue (surgery) with or without radiation, which uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as cemiplimab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cemiplimab has been approved for the treatment of skin cancer that has spread or that cannot be removed by surgery, but it has not been approved for the treatment of skin cancer than can be removed by surgery. Adding cemiplimab to the usual treatment of surgery with or without radiation may be more effective in treating patients with stage III/IV resectable squamous cell skin cancer than the usual treatment alone.
Recruiting2 awards Phase 37 criteria
Immunotherapy + Prednisone + Sirolimus
for Skin Cancer
This phase II trial tests the combination of nivolumab and ipilimumab with sirolimus and prednisone for the treatment of skin (cutaneous) cancer that cannot be removed by surgery (unresectable) or that has spread from where it first started to other places in the body (metastatic) in kidney transplant recipients. Immunotherapy with nivolumab and ipilimumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Sirolimus and prednisone are immunosuppressants that are given to keep the body from rejecting the transplanted kidney. Giving nivolumab and ipilimumab in combination with sirolimus and prednisone may kill more cancer cells, while also keeping the transplanted kidney healthy, in patients with unresectable or metastatic cutaneous cancer who have received a kidney transplant.
Recruiting1 award Phase 1 & 210 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Miami Miller School of Medicine-Sylvester Cancer Center?
University of Miami Miller School of Medicine-Sylvester Cancer Center is a medical facility located in Miami, Florida. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Brain Tumor, Lymphoma and other specialties. University of Miami Miller School of Medicine-Sylvester Cancer Center is involved with conducting 793 clinical trials across 803 conditions. There are 85 research doctors associated with this hospital, such as Julio C Barredo, MD, Jose Lutzky, MD, Chukwuemeka (Emeka) V. Ikpeazu, and Macarena I. De La Fuente.
Where is University of Miami Miller School of Medicine-Sylvester Cancer Center located?
**University of Miami Miller School of Medicine-Sylvester Cancer Center**
- **Address:** 1475 NW 12th Ave, Miami, FL 33136
- **Hours:** Monday to Friday, 8:00 a.m. - 5:00 p.m.
- **Transportation:** Accessible by driving, public transportation, or the UHealth shuttle service.
Who should I call to ask about financial aid or insurance network?
**University of Miami Miller School of Medicine Financial Assistance:**
- For scholarships, grants, and loans, contact the Office of Financial Assistance at **305-243-2900** or visit their website.
**Sylvester Comprehensive Cancer Center Insurance Inquiries:**
- For insurance-related questions, call **305-689-7079** or check the insurance plans accepted page for coverage details.
What insurance does University of Miami Miller School of Medicine-Sylvester Cancer Center accept?
The University of Miami Miller School of Medicine-Sylvester Cancer Center accepts the Aetna Student Health insurance plan, mandatory for international students and optional for domestic students with the possibility to waive it for adequate personal coverage. The plan includes dental coverage within Florida and limited emergency dental care outside Florida; students must use a Florida address to enroll and select a Primary Care Dentist (PCD). Additionally, optional Vision Coverage is available through Aetna Vision Preferred, and Aetna is the primary behavioral health administrator, with Carisk included in a pilot program for enhanced mental and behavioral health services access.
What awards or recognition has University of Miami Miller School of Medicine-Sylvester Cancer Center received?
The University of Miami Miller School of Medicine-Sylvester Cancer Center collaborates with Moffitt Cancer Center and the University of Florida Health Cancer Center, receiving a $16,000 community grant for cancer detection and prevention. It benefits from multiple projects funded by the National Cancer Institute and other external agencies, including pharmaceutical companies. Additionally, the center provides internal awards like Dean's NIH Bridge grants, Research Support Awards, and a Grant Editing Support Program to bolster faculty research.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.